Activity of a novel HER2 inhibitor, poziotinib, for HER2 exon 20 mutations in lung cancer and mechanism of acquired resistance: An in vitro study

Bibliographic Details
Title: Activity of a novel HER2 inhibitor, poziotinib, for HER2 exon 20 mutations in lung cancer and mechanism of acquired resistance: An in vitro study
Authors: Koga, Takamasa, Kobayashi, Yoshihisa, Tomizawa, Kenji, Suda, Kenichi, Kosaka, Takayuki, Sesumi, Yuichi, Fujino, Toshio, Nishino, Masaya, Ohara, Shuta, Chiba, Masato, Shimoji, Masaki, Takemoto, Toshiki, Suzuki, Makoto, Jänne, Pasi A., Mitsudomi, Tetsuya
Source: In Lung Cancer December 2018 126:72-79
Database: ScienceDirect
More Details
ISSN:01695002
DOI:10.1016/j.lungcan.2018.10.019
Published in:Lung Cancer
Language:English